Generic Name : Recombinant Human Erythropoietin
Packing : Pre-Filled Syringe : 1000IU/2000IU/3000IU each of 0.3ml, 4000IU of 0.4ml, 5000IU/20000IU each of 0.5ml, 6000IU of 0.6ml, 10000IU/30000IU/ 40000IU each of 1ml.
Box contains 10 individual packs each
Indication :Dosage and Indication from Generic
- Treatment of anemia associated with renal insufficiency or chronic renal failure (CRF), and for patients on hemodialysis and patients with CRF not requiring hemodialysis; and in pediatric patients on hemodialysis.
- Treatment of anemia in cancer patien
Dosage & Administration : Administration:
Erythropoietin is administered as IV or SC injection, 2-3 times/week. Intravenous administration for patients on hemodialysis and subcutaneous administration for patients on non-hemodialysis and CAPD is recommended. SC route is preferred f
For Anaemia associated in CKD patients:
Starting dose 100 to 150 I.U./kg three times per week IV or SC
For Anaemia related to Cancer or Chemotherapy-induced Anaemia: usual dosage is 150 units/kg administered subcutaneously thrice a week. In case of inadequate response after 8 weeks of therapy, increase the dose every 4 weeks up to a maximum of 300 units/k
Pediatric hemodialysis patients: The recommended initial dose in pediatric patients is 50 IU/kg IV thrice a week. Maintenance dose can be followed by reducing appropriately.
Zidovudine-treated, HIV infected patients: Patients with EPO levels greater than 500 mU/ml are not likely to respond): IV/SC 100 units/kg thrice a week for 8 weeks. Evaluate response every 4 to 8 weeks and adjus
Surgery patients (Adults only): 300 units/kg/day SC for 10 days before surgery, on the day of surgery, and for 4 days after surgery or 600 units/kg SC in once weekly doses (21, 14 and 7 days be
Therapeutic Segement : Haematopoietics
Our Brand Name : EPOTOP
Presentation : Pre-filled Syringes & Vials